Researchers explore the therapeutic potential and clinical insights of GP1-RAs in the management of metabolic dysfunction-associated steatotic liver disease.
Revolutionizing MASLD treatment with GLP-1 receptor agonists
- Post author:
- Post published:December 16, 2024
- Post category:uncategorized